The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it strong buy, with a mean price target of $131.
Agilysys, Inc. AGYS
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $111.27
Agilysys, Inc. holds its Markup at $111.27.
- PHPhase · the trend structure carries the Markup label
- INInsiders · insiders sold, $21,285,243, latest filing 2026-08-05
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 16 days |
| Price | $111.27 |
| Valuation | 73.20 trailing · 34.76 forward price to earnings |
| Values screen | PASS |
| Beta | 0.37 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $107.87 fair value estimate, moderate competitive moat, 14.30% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 14.30% |
| Profit margin | 12.99% |
| Debt to equity | 5.45 |
| Analyst consensus | Strong Buy · 6 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 1.1% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 4.3% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Agilysys Trades Above Fair Value With Little Room
Every time a hotel upgrades its booking system or a resort streamlines its kitchen orders the software must keep pace with real operations. Agilysys supplies those tools yet we pass. The shares sit just above our fair value estimate and carry a forward multiple of 33.5 times for revenue growth of only 12 percent.
Profit margins stand at 12 percent and return on equity reaches 13 percent with a moderate moat. Those figures are respectable and the ethical screen clears without issue. Still the valuation offers no meaningful buffer against slower hospitality spending.
High multiples on steady but unspectacular returns often leave investors exposed when growth moderates. The six analyst targets sit well above current levels yet the modest margin of safety tells its own story. Analysis, not advice.
| Forward P/E | 34.8x expensive even after accounting for its growth |
| Trailing P/E | 73.2x expensive — the price assumes strong growth ahead |
| Revenue growth | 14.3% steady growth |
| Profit margin | 13.0% thin but positive margins |
| Return on equity | 13.8% a solid return on shareholder capital |
| Debt to equity | 0.05 minimal debt — a conservative balance sheet |
| Current ratio | 1.74 healthy short-term liquidity |
| Beta | 0.37 barely tracks the market's swings |
| Market cap | $3.1B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in AGYS's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
AGYS trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it strong buy, with a mean price target of $131.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it strong buy, with a mean price target of $131.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Srinivasan Ramesh | Pres, CEO | S - Sale | 197,410 | $21,285,243 |
| 2026-03-17 | KEATING MELVIN L | Director | 400 | $27,289 | |
| 2026-03-10 | SRINIVASAN RAMESH | Chief Executive Officer | 45,238 | $3,316,398 | |
| 2026-02-03 | KEATING MELVIN L | Director | 600 | $50,379 | |
| 2025-12-04 | JONES DANA SUE | Director | 2,810 | · | |
| 2025-11-21 | COLVIN DONALD A | Director | 6,000 | $739,680 | |
| 2025-11-12 | ROBERTSON CHRIS J | Officer | 500 | $65,670 | |
| 2025-11-04 | WOOD WILLIAM DAVID III | Chief Financial Officer | 584 | $73,117 | |
| 2025-11-03 | BADGER KYLE C | General Counsel | 502 | $62,569 | |
| 2025-11-03 | ROBERTSON CHRIS J | Officer | 400 | $49,856 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $69.09 | +31.9% | · | $1,319 | +31.9% |
| 2 months | $62.19 | +46.5% | · | $1,465 | +46.5% |
| 3 months | $69.95 | +30.3% | · | $1,303 | +30.3% |
| 6 months | $124.24 | -26.7% | · | $734 | -26.7% |
| 1 year | $111.32 | -18.1% | · | $819 | -18.1% |
| 2 years | $91.89 | -0.8% | · | $992 | -0.8% |
| 3 years | $72.88 | +25.1% | · | $1,251 | +25.1% |
| 5 years | $56.29 | +61.9% | · | $1,619 | +61.9% |
Historical returns from market close data. Past performance does not guarantee future results.